slides · global inventory
Evidence
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 40,452
Current window 2,371-2,400
Pages 1,349
Rows per page 30
Beat
2,371-2,400 of 40,452
16
Data derived from L.E.K. 2021, 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
17
Data from L.E.K. 2021, 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
18
Data derived from L.E.K. 2021 and 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
19
Data based on a survey of 120 respondents regarding sales representative outreach/presence.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
20
Data from L.E.K. 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
04
The table includes bilingual (English/Chinese) labels for spending categories.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
05
The chart highlights top priorities for hospitals regarding pharma support, with a specific callout regarding NRDL negotiation and VBP impact on drug costs.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
06
Data from L.E.K. 2023 APAC Hospital Priorities Survey (N=100).Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
07
The slide uses a consistent color-coded legend for years (2021, 2022, 2023) across three bar charts.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
08
NRDL = National Reimbursement Drug List. Data from L.E.K. APAC Hospital Priorities Survey.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
09
The slide uses a stacked bar chart approach to visualize survey data regarding prescription outflow shifts.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
10
The chart shows a clear shift toward higher acceptance of digital engagement in 2023 compared to 2022 across all hospital segments.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
11
The slide uses a bilingual (Chinese/English) format for labels.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
12
Includes a specific callout explaining a spike in privacy concerns due to China's PIPL law.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
13
The slide uses a stacked bar chart approach to visualize survey responses regarding financial health.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
06
The chart uses a grouped bar format to compare 'Before' and 'After' confidence scores (0-10 scale) with percentage change annotations.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
07
The chart uses a multi-select survey format, so percentages may not sum to 100%.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
08
The chart uses a custom layout with a central axis and directional arrows to indicate sentiment/impact.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
09
The chart displays multi-select survey data.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
10
The chart displays survey results regarding the impact of the US BIOSECURE Act on partnering intentions.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
37
The slide uses a dual bar chart layout to compare two time periods. The data represents survey responses from 562 tradespeople.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
38
The chart uses a custom dot-plot style to show the delta between pre-COVID, April, and June activity levels.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
39
The chart uses a vertical dashed line to mark the introduction of the HomeBuilder policy.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
40
The slide uses stacked bar charts to visualize survey data (n=562) across two categories: worksite access and material sourcing.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
41
The slide uses a line chart to show historical emissions data and a callout to highlight the specific drop in the June 2020 quarter.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
42
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
43
The slide uses a structured list format to map behavioural drivers to specific infrastructure impacts and their 'stickiness'.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
44
The chart uses a diverging bar structure to represent 'Never' (negative values) vs 'Working from home' (positive values).Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
45
The charts highlight the top three responses in green, with the rest in dark blue.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
46
Includes two line charts showing net migration and arrivals/departures, supported by bulleted behavioral insights.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit